Botulinum toxin complications in registered and off-label aesthetic indications

Autor:	Ada Trindade de Almeida, Marina Landau, Mark S Nestor, Firas Al-Niaimi
Rok vydání:	2020
Předmět:	2019-20 coronavirus outbreak medicine.medical_specialty complications Esthetics Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Dermatology Off-label use Botulinum toxin a 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Intervention (counseling) medicine Humans botulinum toxin Botulinum Toxins Type A Adverse effect Intensive care medicine Cosmetic procedures business.industry Off-Label Use Botulinum toxin Neuromuscular Agents 030220 oncology & carcinogenesis business medicine.drug
Zdroj:	Landau, M, Nestor, M S, de Almeida, A T & Al-Niaimi, F 2020, ' Botulinum toxin complications in registered and off-label aesthetic indications ', Journal of Cosmetic Dermatology, vol. 19, no. 10, pp. 2484-2490 . https://doi.org/10.1111/jocd.13667
ISSN:	1473-2165
DOI:	10.1111/jocd.13667
Popis:	Botulinum toxin A (BTXA) is one of the most popular nonsurgical cosmetic procedures worldwide. Overall, this procedure is associated with favorable complications profile. Nevertheless, any medical intervention carries inherent risks. This synopsis systematically reviews adverse effects of aesthetic BTXA for both approved and off-label indications. Based on published data, the approach for prevention and management is discussed.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f005cf1cce01daaca05ed97df11bf9 https://pubmed.ncbi.nlm.nih.gov/32857479 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.